MBX in the 13F filings
MBX Biosciences Inc · CUSIP 55287L101
- Quarter end
- 30 Sep 2026
- the date the book describes
- Filed
- 16 Nov 2026
- latest of these filings; the earliest 9 Nov 2026
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 46
- filed both Q2 2026 and Q3 2026; 4 listed it in both
- Shares listed
- 14,671,268
- combined, among listed positions
- Reported value
- $860m
- combined, at the quarter end
Among the 89 comparable managers: 9 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,274,710.
Managers listing MBX in Q3 2026
19 of 19 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 7,368,420 shares now+2,045,535
- Wellington Management Group LLPexisting position · 5,164,535 shares now+187,012
- Invesco Ltdexisting position · 142,669 shares now+91,991
- Polen Capital Management LLCnew position · 39,480 shares now+39,480
- Winton Group Ltdnew position · 13,718 shares now+13,718
Reductions
- Marshall Wace LLPexisting position · 113,023 shares now-288,862
- Woodline Partners LPexisting position · 653,972 shares now-246,120
- T. Rowe Price Associates Incexisting position · 621,624 shares now-193,183
- Schonfeld Strategic Advisors LLCexisting position · 158,104 shares now-90,566
- D. E. Shaw & Co.existing position · 127,305 shares now-55,462
New positions and exits
New (5)
Exited (2)
- Millennium Management LLCwas $12m
- Brevan Howard Capital Management LPwas $475k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2024 | 3 | $15m | 3 | 0 |
| Q4 2024 | 1 | $11m | 1 | 2 |
| Q1 2025 | 1 | $6.5m | 1 | 0 |
| Q2 2025 | 2 | $17m | 2 | 0 |
| Q3 2025 | 1 | $21m | 1 | 0 |
| Q4 2025 | 1 | $32m | 14 | 11 |
| Q1 2026 | 1 | $27m | 9 | 15 |
| Q2 2026 | 4 | $342m | 11 | 10 |
| Q3 2026 | 5 | $356m | 9 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MBX and LLY →MBX and TMO →MBX and JNJ →Choose a stock to compare with MBX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MBX, latest filings →Back to the 13F Explorer →